BOSTON--(BUSINESS WIRE)-- Today, 908 Devices Inc. (MASS) (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of ...
908 Devices (MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ Maven for automated control of glucose and lactate levels in cell cultures. The ...
New York, USA, March 06, 2025 (GLOBE NEWSWIRE) -- Global Single-use Bioreactors Market to Cross ~USD 10 Billion Mark by 2032 | DelveInsight The widespread adoption of single-use technologies, ...
4 th June, 2024, Morgan Hill, USA and Delft, Netherlands: Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and ...
GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon ...
Single-Use Bioreactor Market is expected to reach USD 11.2 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 18% from 2024 to 2031. BURLINGAME, CA, UNITED STATES, October 1, 2024 ...
The validation study was conducted at Aragen's state-of-the-art R&D facility in Morgan Hill, California. It demonstrated the SUPR bioreactor's exceptional performance in generating high-quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback